Committee on Obstetric Practice: The American College of Nurse–Midwives and the Society for Maternal–Fetal Medicine endorse this document. The American Academy of Family Physicians and the Association of Women’s Health, Obstetric and Neonatal Nurses support this document. This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice in collaboration with committee members Ann E. Borders, MD, MSc, MPH and Alison M. Stuebe, MD, MSc, and reviewed by the Long-Acting Reversible Contraception Work Group.
This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed.
Copyright August 2016 by the American College of Obstetricians and Gynecologists. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, posted on the Internet, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior written permission from the publisher.
Requests for authorization to make photocopies should be directed to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400.
The American College of Obstetricians and Gynecologists 409 12th Street, SW, PO Box 96920, Washington, DC 20090-6920
Immediate postpartum long-acting reversible contraception. Commit-tee Opinion No. 670. American College of Obstetricians and Gyne-cologists. Obstet Gynecol 2016;128:e32–7.
* This section includes guidance based on the 2010 U.S Medical Eligibility Criteria for Contraceptive Use from the Centers for Disease Control and Prevention. Updates to these recommendations are available on the Centers for Disease Control and Prevention web site (http://www.cdc.gov/reproductivehealth/UnintendedPregnancy/USMEC.htm).
